カテゴリ： 世界, 医療/バイオ, Market Monitor Global

GIP-1受容体作動薬のグローバル市場展望 2023年-2029年：短時間作用型GLP-1受容体作動薬、長時間作用型GLP-1受容体作動薬

■ 英語タイトル：GIP-1 Receptor Agonist Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14343）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14343
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[GIP-1受容体作動薬のグローバル市場展望 2023年-2029年：短時間作用型GLP-1受容体作動薬、長時間作用型GLP-1受容体作動薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のGIP-1受容体作動薬市場規模と予測を収録しています。・世界のGIP-1受容体作動薬市場：売上、2018年-2023年、2024年-2029年
・世界のGIP-1受容体作動薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のGIP-1受容体作動薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「短時間作用型GLP-1受容体作動薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

GIP-1受容体作動薬のグローバル主要企業は、GSK、 Novo Nordisk、 Eli Lilly and Company、 Baxter Pharmaceutical Solutions、 Sanofi、 AstraZeneca、 Shanghai Benemae Pharmaceutical Corporation、 Sinopep Allsino Bio Pharmaceutical、 Huadong Medicine、 HANSOH PHARMA、 3SBioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、GIP-1受容体作動薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のGIP-1受容体作動薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のGIP-1受容体作動薬市場：タイプ別市場シェア、2022年
・短時間作用型GLP-1受容体作動薬、長時間作用型GLP-1受容体作動薬

世界のGIP-1受容体作動薬市場：用途別、2018年-2023年、2024年-2029年
世界のGIP-1受容体作動薬市場：用途別市場シェア、2022年
・型糖尿病患者、肥満患者、その他

世界のGIP-1受容体作動薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のGIP-1受容体作動薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるGIP-1受容体作動薬のグローバル売上、2018年-2023年
・主要企業におけるGIP-1受容体作動薬のグローバル売上シェア、2022年
・主要企業におけるGIP-1受容体作動薬のグローバル販売量、2018年-2023年
・主要企業におけるGIP-1受容体作動薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Novo Nordisk、 Eli Lilly and Company、 Baxter Pharmaceutical Solutions、 Sanofi、 AstraZeneca、 Shanghai Benemae Pharmaceutical Corporation、 Sinopep Allsino Bio Pharmaceutical、 Huadong Medicine、 HANSOH PHARMA、 3SBio

*************************************************************

・調査・分析レポートの概要
GIP-1受容体作動薬市場の定義
市場セグメント
世界のGIP-1受容体作動薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のGIP-1受容体作動薬市場規模
世界のGIP-1受容体作動薬市場規模：2022年 VS 2029年
世界のGIP-1受容体作動薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのGIP-1受容体作動薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のGIP-1受容体作動薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：短時間作用型GLP-1受容体作動薬、長時間作用型GLP-1受容体作動薬
GIP-1受容体作動薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：型糖尿病患者、肥満患者、その他
GIP-1受容体作動薬の用途別グローバル売上・予測

・地域別市場分析
地域別GIP-1受容体作動薬市場規模 2022年と2029年
地域別GIP-1受容体作動薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Novo Nordisk、 Eli Lilly and Company、 Baxter Pharmaceutical Solutions、 Sanofi、 AstraZeneca、 Shanghai Benemae Pharmaceutical Corporation、 Sinopep Allsino Bio Pharmaceutical、 Huadong Medicine、 HANSOH PHARMA、 3SBio
...

This research report provides a comprehensive analysis of the GIP-1 Receptor Agonist market, focusing on the current trends, market dynamics, and future prospects. The report explores the global GIP-1 Receptor Agonist market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of GIP-1 Receptor Agonist, challenges faced by the industry, and potential opportunities for market players.
The global GIP-1 Receptor Agonist market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The GIP-1 Receptor Agonist market presents opportunities for various stakeholders, including Type 2 Diabetics, Obese Patients. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in GIP-1 Receptor Agonist market. Additionally, the growing consumer demand present avenues for market expansion.
The global GIP-1 Receptor Agonist market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the GIP-1 Receptor Agonist market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the GIP-1 Receptor Agonist market.
Market Overview: The report provides a comprehensive overview of the GIP-1 Receptor Agonist market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Short-acting GLP-1 Receptor Agonist, Long-acting GLP-1 Receptor Agonist), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the GIP-1 Receptor Agonist market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the GIP-1 Receptor Agonist market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the GIP-1 Receptor Agonist market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the GIP-1 Receptor Agonist market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the GIP-1 Receptor Agonist market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the GIP-1 Receptor Agonist market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for GIP-1 Receptor Agonist, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the GIP-1 Receptor Agonist market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
GIP-1 Receptor Agonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Short-acting GLP-1 Receptor Agonist
Long-acting GLP-1 Receptor Agonist
Market segment by Application
Type 2 Diabetics
Obese Patients
Others
Global GIP-1 Receptor Agonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GSK
Novo Nordisk
Eli Lilly and Company
Baxter Pharmaceutical Solutions
Sanofi
AstraZeneca
Shanghai Benemae Pharmaceutical Corporation
Sinopep Allsino Bio Pharmaceutical
Huadong Medicine
HANSOH PHARMA
3SBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of GIP-1 Receptor Agonist, market overview.
Chapter 2: Global GIP-1 Receptor Agonist market size in revenue and volume.
Chapter 3: Detailed analysis of GIP-1 Receptor Agonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GIP-1 Receptor Agonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global GIP-1 Receptor Agonist capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 GIP-1 Receptor Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GIP-1 Receptor Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GIP-1 Receptor Agonist Overall Market Size
2.1 Global GIP-1 Receptor Agonist Market Size: 2022 VS 2029
2.2 Global GIP-1 Receptor Agonist Revenue, Prospects & Forecasts: 2018-2029
2.3 Global GIP-1 Receptor Agonist Sales: 2018-2029
3 Company Landscape
3.1 Top GIP-1 Receptor Agonist Players in Global Market
3.2 Top Global GIP-1 Receptor Agonist Companies Ranked by Revenue
3.3 Global GIP-1 Receptor Agonist Revenue by Companies
3.4 Global GIP-1 Receptor Agonist Sales by Companies
3.5 Global GIP-1 Receptor Agonist Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 GIP-1 Receptor Agonist Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers GIP-1 Receptor Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 GIP-1 Receptor Agonist Players in Global Market
3.8.1 List of Global Tier 1 GIP-1 Receptor Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 GIP-1 Receptor Agonist Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global GIP-1 Receptor Agonist Market Size Markets, 2022 & 2029
4.1.2 Short-acting GLP-1 Receptor Agonist
4.1.3 Long-acting GLP-1 Receptor Agonist
4.2 By Type – Global GIP-1 Receptor Agonist Revenue & Forecasts
4.2.1 By Type – Global GIP-1 Receptor Agonist Revenue, 2018-2023
4.2.2 By Type – Global GIP-1 Receptor Agonist Revenue, 2024-2029
4.2.3 By Type – Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
4.3 By Type – Global GIP-1 Receptor Agonist Sales & Forecasts
4.3.1 By Type – Global GIP-1 Receptor Agonist Sales, 2018-2023
4.3.2 By Type – Global GIP-1 Receptor Agonist Sales, 2024-2029
4.3.3 By Type – Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
4.4 By Type – Global GIP-1 Receptor Agonist Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global GIP-1 Receptor Agonist Market Size, 2022 & 2029
5.1.2 Type 2 Diabetics
5.1.3 Obese Patients
5.1.4 Others
5.2 By Application – Global GIP-1 Receptor Agonist Revenue & Forecasts
5.2.1 By Application – Global GIP-1 Receptor Agonist Revenue, 2018-2023
5.2.2 By Application – Global GIP-1 Receptor Agonist Revenue, 2024-2029
5.2.3 By Application – Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
5.3 By Application – Global GIP-1 Receptor Agonist Sales & Forecasts
5.3.1 By Application – Global GIP-1 Receptor Agonist Sales, 2018-2023
5.3.2 By Application – Global GIP-1 Receptor Agonist Sales, 2024-2029
5.3.3 By Application – Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
5.4 By Application – Global GIP-1 Receptor Agonist Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global GIP-1 Receptor Agonist Market Size, 2022 & 2029
6.2 By Region – Global GIP-1 Receptor Agonist Revenue & Forecasts
6.2.1 By Region – Global GIP-1 Receptor Agonist Revenue, 2018-2023
6.2.2 By Region – Global GIP-1 Receptor Agonist Revenue, 2024-2029
6.2.3 By Region – Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
6.3 By Region – Global GIP-1 Receptor Agonist Sales & Forecasts
6.3.1 By Region – Global GIP-1 Receptor Agonist Sales, 2018-2023
6.3.2 By Region – Global GIP-1 Receptor Agonist Sales, 2024-2029
6.3.3 By Region – Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America GIP-1 Receptor Agonist Revenue, 2018-2029
6.4.2 By Country – North America GIP-1 Receptor Agonist Sales, 2018-2029
6.4.3 US GIP-1 Receptor Agonist Market Size, 2018-2029
6.4.4 Canada GIP-1 Receptor Agonist Market Size, 2018-2029
6.4.5 Mexico GIP-1 Receptor Agonist Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe GIP-1 Receptor Agonist Revenue, 2018-2029
6.5.2 By Country – Europe GIP-1 Receptor Agonist Sales, 2018-2029
6.5.3 Germany GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.4 France GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.5 U.K. GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.6 Italy GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.7 Russia GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.8 Nordic Countries GIP-1 Receptor Agonist Market Size, 2018-2029
6.5.9 Benelux GIP-1 Receptor Agonist Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia GIP-1 Receptor Agonist Revenue, 2018-2029
6.6.2 By Region – Asia GIP-1 Receptor Agonist Sales, 2018-2029
6.6.3 China GIP-1 Receptor Agonist Market Size, 2018-2029
6.6.4 Japan GIP-1 Receptor Agonist Market Size, 2018-2029
6.6.5 South Korea GIP-1 Receptor Agonist Market Size, 2018-2029
6.6.6 Southeast Asia GIP-1 Receptor Agonist Market Size, 2018-2029
6.6.7 India GIP-1 Receptor Agonist Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America GIP-1 Receptor Agonist Revenue, 2018-2029
6.7.2 By Country – South America GIP-1 Receptor Agonist Sales, 2018-2029
6.7.3 Brazil GIP-1 Receptor Agonist Market Size, 2018-2029
6.7.4 Argentina GIP-1 Receptor Agonist Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa GIP-1 Receptor Agonist Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa GIP-1 Receptor Agonist Sales, 2018-2029
6.8.3 Turkey GIP-1 Receptor Agonist Market Size, 2018-2029
6.8.4 Israel GIP-1 Receptor Agonist Market Size, 2018-2029
6.8.5 Saudi Arabia GIP-1 Receptor Agonist Market Size, 2018-2029
6.8.6 UAE GIP-1 Receptor Agonist Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK GIP-1 Receptor Agonist Major Product Offerings
7.1.4 GSK GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk GIP-1 Receptor Agonist Major Product Offerings
7.2.4 Novo Nordisk GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.2.5 Novo Nordisk Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company GIP-1 Receptor Agonist Major Product Offerings
7.3.4 Eli Lilly and Company GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 Baxter Pharmaceutical Solutions
7.4.1 Baxter Pharmaceutical Solutions Company Summary
7.4.2 Baxter Pharmaceutical Solutions Business Overview
7.4.3 Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Major Product Offerings
7.4.4 Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.4.5 Baxter Pharmaceutical Solutions Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi GIP-1 Receptor Agonist Major Product Offerings
7.5.4 Sanofi GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca GIP-1 Receptor Agonist Major Product Offerings
7.6.4 AstraZeneca GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Shanghai Benemae Pharmaceutical Corporation
7.7.1 Shanghai Benemae Pharmaceutical Corporation Company Summary
7.7.2 Shanghai Benemae Pharmaceutical Corporation Business Overview
7.7.3 Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Major Product Offerings
7.7.4 Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.7.5 Shanghai Benemae Pharmaceutical Corporation Key News & Latest Developments
7.8 Sinopep Allsino Bio Pharmaceutical
7.8.1 Sinopep Allsino Bio Pharmaceutical Company Summary
7.8.2 Sinopep Allsino Bio Pharmaceutical Business Overview
7.8.3 Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Major Product Offerings
7.8.4 Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.8.5 Sinopep Allsino Bio Pharmaceutical Key News & Latest Developments
7.9 Huadong Medicine
7.9.1 Huadong Medicine Company Summary
7.9.2 Huadong Medicine Business Overview
7.9.3 Huadong Medicine GIP-1 Receptor Agonist Major Product Offerings
7.9.4 Huadong Medicine GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.9.5 Huadong Medicine Key News & Latest Developments
7.10 HANSOH PHARMA
7.10.1 HANSOH PHARMA Company Summary
7.10.2 HANSOH PHARMA Business Overview
7.10.3 HANSOH PHARMA GIP-1 Receptor Agonist Major Product Offerings
7.10.4 HANSOH PHARMA GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.10.5 HANSOH PHARMA Key News & Latest Developments
7.11 3SBio
7.11.1 3SBio Company Summary
7.11.2 3SBio Business Overview
7.11.3 3SBio GIP-1 Receptor Agonist Major Product Offerings
7.11.4 3SBio GIP-1 Receptor Agonist Sales and Revenue in Global (2018-2023)
7.11.5 3SBio Key News & Latest Developments
8 Global GIP-1 Receptor Agonist Production Capacity, Analysis
8.1 Global GIP-1 Receptor Agonist Production Capacity, 2018-2029
8.2 GIP-1 Receptor Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global GIP-1 Receptor Agonist Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GIP-1 Receptor Agonist Supply Chain Analysis
10.1 GIP-1 Receptor Agonist Industry Value Chain
10.2 GIP-1 Receptor Agonist Upstream Market
10.3 GIP-1 Receptor Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GIP-1 Receptor Agonist Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of GIP-1 Receptor Agonist in Global Market
Table 2. Top GIP-1 Receptor Agonist Players in Global Market, Ranking by Revenue (2022)
Table 3. Global GIP-1 Receptor Agonist Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global GIP-1 Receptor Agonist Revenue Share by Companies, 2018-2023
Table 5. Global GIP-1 Receptor Agonist Sales by Companies, (K Units), 2018-2023
Table 6. Global GIP-1 Receptor Agonist Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers GIP-1 Receptor Agonist Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers GIP-1 Receptor Agonist Product Type
Table 9. List of Global Tier 1 GIP-1 Receptor Agonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GIP-1 Receptor Agonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global GIP-1 Receptor Agonist Sales (K Units), 2018-2023
Table 15. By Type - Global GIP-1 Receptor Agonist Sales (K Units), 2024-2029
Table 16. By Application – Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global GIP-1 Receptor Agonist Sales (K Units), 2018-2023
Table 20. By Application - Global GIP-1 Receptor Agonist Sales (K Units), 2024-2029
Table 21. By Region – Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global GIP-1 Receptor Agonist Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global GIP-1 Receptor Agonist Sales (K Units), 2018-2023
Table 25. By Region - Global GIP-1 Receptor Agonist Sales (K Units), 2024-2029
Table 26. By Country - North America GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America GIP-1 Receptor Agonist Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America GIP-1 Receptor Agonist Sales, (K Units), 2018-2023
Table 29. By Country - North America GIP-1 Receptor Agonist Sales, (K Units), 2024-2029
Table 30. By Country - Europe GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe GIP-1 Receptor Agonist Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe GIP-1 Receptor Agonist Sales, (K Units), 2018-2023
Table 33. By Country - Europe GIP-1 Receptor Agonist Sales, (K Units), 2024-2029
Table 34. By Region - Asia GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia GIP-1 Receptor Agonist Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia GIP-1 Receptor Agonist Sales, (K Units), 2018-2023
Table 37. By Region - Asia GIP-1 Receptor Agonist Sales, (K Units), 2024-2029
Table 38. By Country - South America GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America GIP-1 Receptor Agonist Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America GIP-1 Receptor Agonist Sales, (K Units), 2018-2023
Table 41. By Country - South America GIP-1 Receptor Agonist Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa GIP-1 Receptor Agonist Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa GIP-1 Receptor Agonist Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa GIP-1 Receptor Agonist Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK GIP-1 Receptor Agonist Product Offerings
Table 48. GSK GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Novo Nordisk Company Summary
Table 51. Novo Nordisk GIP-1 Receptor Agonist Product Offerings
Table 52. Novo Nordisk GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Novo Nordisk Key News & Latest Developments
Table 54. Eli Lilly and Company Company Summary
Table 55. Eli Lilly and Company GIP-1 Receptor Agonist Product Offerings
Table 56. Eli Lilly and Company GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Eli Lilly and Company Key News & Latest Developments
Table 58. Baxter Pharmaceutical Solutions Company Summary
Table 59. Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Product Offerings
Table 60. Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Baxter Pharmaceutical Solutions Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi GIP-1 Receptor Agonist Product Offerings
Table 64. Sanofi GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca GIP-1 Receptor Agonist Product Offerings
Table 68. AstraZeneca GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Shanghai Benemae Pharmaceutical Corporation Company Summary
Table 71. Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Product Offerings
Table 72. Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shanghai Benemae Pharmaceutical Corporation Key News & Latest Developments
Table 74. Sinopep Allsino Bio Pharmaceutical Company Summary
Table 75. Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Product Offerings
Table 76. Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sinopep Allsino Bio Pharmaceutical Key News & Latest Developments
Table 78. Huadong Medicine Company Summary
Table 79. Huadong Medicine GIP-1 Receptor Agonist Product Offerings
Table 80. Huadong Medicine GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Huadong Medicine Key News & Latest Developments
Table 82. HANSOH PHARMA Company Summary
Table 83. HANSOH PHARMA GIP-1 Receptor Agonist Product Offerings
Table 84. HANSOH PHARMA GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. HANSOH PHARMA Key News & Latest Developments
Table 86. 3SBio Company Summary
Table 87. 3SBio GIP-1 Receptor Agonist Product Offerings
Table 88. 3SBio GIP-1 Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. 3SBio Key News & Latest Developments
Table 90. GIP-1 Receptor Agonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global GIP-1 Receptor Agonist Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global GIP-1 Receptor Agonist Production by Region, 2018-2023 (K Units)
Table 93. Global GIP-1 Receptor Agonist Production by Region, 2024-2029 (K Units)
Table 94. GIP-1 Receptor Agonist Market Opportunities & Trends in Global Market
Table 95. GIP-1 Receptor Agonist Market Drivers in Global Market
Table 96. GIP-1 Receptor Agonist Market Restraints in Global Market
Table 97. GIP-1 Receptor Agonist Raw Materials
Table 98. GIP-1 Receptor Agonist Raw Materials Suppliers in Global Market
Table 99. Typical GIP-1 Receptor Agonist Downstream
Table 100. GIP-1 Receptor Agonist Downstream Clients in Global Market
Table 101. GIP-1 Receptor Agonist Distributors and Sales Agents in Global Market
List of Figures
Figure 1. GIP-1 Receptor Agonist Segment by Type in 2022
Figure 2. GIP-1 Receptor Agonist Segment by Application in 2022
Figure 3. Global GIP-1 Receptor Agonist Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global GIP-1 Receptor Agonist Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global GIP-1 Receptor Agonist Revenue, 2018-2029 (US$, Mn)
Figure 7. GIP-1 Receptor Agonist Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by GIP-1 Receptor Agonist Revenue in 2022
Figure 9. By Type - Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 11. By Type - Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 12. By Type - Global GIP-1 Receptor Agonist Price (US$/Unit), 2018-2029
Figure 13. By Application - Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 15. By Application - Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 16. By Application - Global GIP-1 Receptor Agonist Price (US$/Unit), 2018-2029
Figure 17. By Region - Global GIP-1 Receptor Agonist Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global GIP-1 Receptor Agonist Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 20. By Region - Global GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 21. By Country - North America GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 22. By Country - North America GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 23. US GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 24. Canada GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 27. By Country - Europe GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 28. Germany GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 29. France GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 31. Italy GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 32. Russia GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 36. By Region - Asia GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 37. China GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 38. Japan GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 41. India GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 43. By Country - South America GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 44. Brazil GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa GIP-1 Receptor Agonist Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa GIP-1 Receptor Agonist Sales Market Share, 2018-2029
Figure 48. Turkey GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 49. Israel GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 51. UAE GIP-1 Receptor Agonist Revenue, (US$, Mn), 2018-2029
Figure 52. Global GIP-1 Receptor Agonist Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production GIP-1 Receptor Agonist by Region, 2022 VS 2029
Figure 54. GIP-1 Receptor Agonist Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プロゲステロン受容体作動薬のグローバル市場展望 2023年-2029年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬
  • バソプレシンV1b受容体のグローバル市場展望 2023年-2029年：PHT-103、ABT-436、AVN-628、その他
  • 受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他
  • C5aアナフィラトキシン走化性受容体1のグローバル市場展望 2023年-2029年：EP-67、NOXD-19、NOXD-20、DF-2593A、その他
  • 腫瘍壊死因子受容体スーパーファミリーメンバー1Aのグローバル市場展望 2023年-2029年：LY-3232094、EYS-606、SRT-100、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14343 )"GIP-1受容体作動薬のグローバル市場展望 2023年-2029年：短時間作用型GLP-1受容体作動薬、長時間作用型GLP-1受容体作動薬" (英文：GIP-1 Receptor Agonist Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。